Veru, Inc. (VERU)
2.69
-0.11
(-3.93%)
USD |
NASDAQ |
Sep 01, 16:00
2.74
+0.05
(+1.86%)
Pre-Market: 08:44
Veru Research and Development Expense (Annual) : 15.59M for Sept. 30, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| September 30, 2025 | 15.59M |
| September 30, 2024 | 12.78M |
| September 30, 2023 | 51.20M |
| September 30, 2022 | 70.91M |
| September 30, 2021 | 32.69M |
| September 30, 2020 | 16.94M |
| September 30, 2019 | 13.74M |
| September 30, 2018 | 10.85M |
| September 30, 2017 | 3.076M |
| September 30, 2016 | 0.0994M |
| September 30, 2015 | 0.2198M |
| September 30, 2014 | 0.0056M |
| September 30, 2013 | 0.0047M |
| September 30, 2012 | 0.0053M |
| September 30, 2011 | 0.0109M |
| September 30, 2010 | 0.0004M |
| Date | Value |
|---|---|
| September 30, 2009 | 0.1059M |
| September 30, 2008 | 0.2842M |
| September 30, 2007 | 0.2086M |
| September 30, 2006 | 0.2109M |
| September 30, 2005 | 0.2738M |
| September 30, 2004 | 0.1792M |
| September 30, 2003 | 0.00 |
| September 30, 2002 | 0.00 |
| September 30, 2001 | 0.00 |
| September 30, 2000 | 0.0671M |
| September 30, 1999 | 0.1222M |
| September 30, 1998 | 0.0025M |
| September 30, 1997 | 0.0608M |
| September 30, 1996 | 0.3611M |
| September 30, 1995 | 0.1351M |
| September 30, 1994 | 0.5932M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| ANI Pharmaceuticals, Inc. | 51.66M |
| Corcept Therapeutics, Inc. | 254.91M |
| Johnson & Johnson | 14.83B |
| Eli Lilly & Co. | 13.34B |
| Lexicon Pharmaceuticals, Inc. | 60.50M |